文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

University of Rochester Medical Center, Rochester, NY 14642-8410, USA.

Liver Transpl. 2000 Nov;6(6 Suppl 2):S59-63. doi: 10.1053/jlts.2000.19011.

Living donor liver transplantation (LDLT) is currently performed at about 30 centers in the United States. 2. Careful and critical evaluation of donor and recipient is required for optimal outcome. 3. Right lobe donation is preferred over left lobe donation in adult LDLT. 4. There has been 1 donor death (<0.3%) in the US experiences. Donor biliary complications occur in approximately 4% of the cases. 5. Recipient survival after adult LDLT in the United States is approximately 88%. Hepatic artery thrombosis occurs in 3% and biliary complications in 18%.

活体供肝肝移植（LDLT）目前在美国约30个中心开展。2. 为获得最佳疗效，需要对供体和受体进行仔细且严格的评估。3. 在成人活体供肝肝移植中，右叶供肝优于左叶供肝。4. 在美国的经验中，有1例供体死亡（<0.3%）。约4%的病例发生供体胆道并发症。5. 美国成人活体供肝肝移植术后受体生存率约为88%。肝动脉血栓形成发生率为3%，胆道并发症发生率为18%。

University of Rochester Medical Center, Rochester, NY 14642-8410, USA.

Liver Transpl. 2000 Nov;6(6 Suppl 2):S59-63. doi: 10.1053/jlts.2000.19011.

Living donor liver transplantation (LDLT) is currently performed at about 30 centers in the United States. 2. Careful and critical evaluation of donor and recipient is required for optimal outcome. 3. Right lobe donation is preferred over left lobe donation in adult LDLT. 4. There has been 1 donor death (<0.3%) in the US experiences. Donor biliary complications occur in approximately 4% of the cases. 5. Recipient survival after adult LDLT in the United States is approximately 88%. Hepatic artery thrombosis occurs in 3% and biliary complications in 18%.

活体供肝肝移植（LDLT）目前在美国约30个中心开展。2. 为获得最佳疗效，需要对供体和受体进行仔细且严格的评估。3. 在成人活体供肝肝移植中，右叶供肝优于左叶供肝。4. 在美国的经验中，有1例供体死亡（<0.3%）。约4%的病例发生供体胆道并发症。5. 美国成人活体供肝肝移植术后受体生存率约为88%。肝动脉血栓形成发生率为3%，胆道并发症发生率为18%。